The EBMT risk score (Q37885167)

24 August 2017

1 reference

title

The EBMT risk score (English)

1 reference

24 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21643021

3 December 2024

1

A. Gratwohl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21643021

3 December 2024

language of work or name

English

0 references

publication date

6 June 2011

1 reference

full work available at URL

24 August 2017

https://www.nature.com/articles/bmt2011110.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21643021

https://www.nature.com/articles/bmt2011110.pdf

3 December 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

https://www.nature.com/articles/bmt2011110

3 December 2024

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

Bone Marrow Transplantation

3 December 2024

published in

1 reference

24 August 2017

volume

47

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

749-756

1 reference

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

Bone-marrow transplantation (second of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

Risk assessment in haematopoietic stem cell transplantation: impact of donor-recipient sex combination in allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

21 January 2018

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

Optimal HLA matching in hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

H-Y as a minor histocompatibility antigen in kidney transplantation: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

Reduced mortality after allogeneic hematopoietic-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

Bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

7 January 2021

Alloimmunity to human H-Y

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

7 January 2021

Biological differences in the three major leukaemias

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

7 January 2021

Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

7 January 2021

Allogeneic stem cell transplantation in follicular lymphoma: recent progress and controversy

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

7 January 2021

Bone marrow transplantation for acute nonlymphoblastic leukaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.)

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

7 January 2021

Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

7 January 2021

Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4 T-helper cells in H-Y-mismatched transplantation

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

7 January 2021

Cytomegalovirus in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

7 January 2021

Optimal induction and post-remission therapy for AML in first remission

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

7 January 2021

Risk assessment in haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

7 January 2021

https://api.crossref.org/works/10.1038/BMT.2011.110

11

90

232

CA De Souza

2005

1 reference

3 December 2024

12

91

513

A Gratwohl

2006

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

3 December 2024

41

140

326

J Passweg

2010

1 reference

https://api.crossref.org/works/10.1038/BMT.2011.110

3 December 2024

Identifiers

DOI

10.1038/BMT.2011.110

1 reference

24 August 2017

1 reference